Association Between GATA3 and Histopathological and Immunohistochemical Parameters in Early-Infiltrating Breast Carcinomas
- 1 July 2022
- journal article
- research article
- Published by Galenos Yayinevi in European Journal of Breast Health
- Vol. 18 (3) , 229-234
Abstract
This study evaluated the frequency of GATA-binding protein 3 (GATA3) expression in early breast cancer and its relationship with histopathological and immunohistochemical parameters. GATA3 was analysed by immunohistochemistry in histological sections of tumors from 105 female patients, with histological diagnosis of invasive breast carcinoma (BC), at clinical stages I, II and IIIA, who underwent primary surgical treatment. GATA3 nuclear expression was determined as the percentage of positive tumor cells and further categorized as high (positive expression in more than 95% of cells) or non-high (negative or low positive expression in up to 95% of tumor cells). GATA3 expression was analysed according to the patient age, tumor and node pathological stage, histological type, histological and nuclear grade, lymphovascular invasion, and estrogen receptor (ER), progesterone receptor (PR), androgen receptor (AR), human epidermal growth factor 2 (HER2) status, and Ki-67 expression. GATA3 expression was positive in 103 cases (98.1%). High expression was significantly associated with low histological and nuclear grade, positive hormonal receptors, and less proliferative activity based on Ki-67 expression. A prominent feature was that 94.7% of the ER-positive/HER2-negative cases presented high-GATA3 expression, as 94.0% of the tumors showing high-GATA3 were ER-positive. In ER-negative/HER2-positive or ER-negative/HER2- negative, high-GATA3 was present in 25% while 75% were non-high-GATA3 compared with ER-positive/HER2- negative (4.1%) and ER-positive/HER2-positive (20%). Proliferative activity in triple-negative breast cancer tended to be higher among tumors with low-GATA3, irrespective of AR expression. In the group of ER-positive/HER2-negative tumors only three cases were low-GATA3 (85% and 80%), both with high proliferative activity. High GATA3 expression is associated with favorable histopathologic and immunohistochemical BC prognostic factors.Keywords
This publication has 24 references indexed in Scilit:
- GATA3 zinc finger 2 mutations reprogram the breast cancer transcriptional networkNature Communications, 2018
- GATA3 expression and its relationship with clinicopathological parameters in invasive breast carcinomasPathology - Research and Practice, 2017
- Negative association between GATA3 and fascin could predict relapse-free and overall survival in patients with breast cancerVirchows Archiv, 2015
- GATA3 in Breast Cancer: Tumor Suppressor or Oncogene?Gene Expression, 2015
- GATA-3 expression in male and female breast cancers: comparison of clinicopathologic parameters and prognostic relevanceHuman Pathology, 2013
- Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapiesJournal of Clinical Investigation, 2011
- Higher levels of GATA3 predict better survival in women with breast cancerHuman Pathology, 2010
- GATA-3 Maintains the Differentiation of the Luminal Cell Fate in the Mammary GlandCell, 2006
- Identification of GATA3 as a Breast Cancer Prognostic Marker by Global Gene Expression Meta-analysisCancer Research, 2005
- GATA-3 Expression as a Predictor of Hormone Response in Breast CancerJournal of the American College of Surgeons, 2005